Position in CELC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$31,181,676
+$29,237,416 QoQ
Shares Held
298,047
+1649.7% QoQ
Ownership
0.609%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#41
of 274 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names. CELC ranks #51 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in CELC
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,181,676 | 298,047 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,944,260 | 17,034 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,433,063 | 14,368 | Shares | Defined | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||